U.S. Biosimilars Market Analysis, Size, Share, and Forecast 2031

ha aggiunto un file Health

2024-04-26 10:27:46 -

The U.S. Biosimilars Market in 2023 is US$ 13.27 billion, and is expected to reach US$ 200.59 billion by 2031 at a CAGR of 40.40%. FutureWise Research published a report that analyzes U.S. Biosimilars Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market...

0 Commenti 0 condivisioni 682 Views 0 Anteprima